Noninvasive electromagnetic glucose monitor in development
WACO, Texas A Baylor University researcher is currently developing an electromagnetic sensor that could provide diabetics a noninvasive alternative to reading their blood glucose levels, and new research shows the sensor works and is effective, Baylor University announced Monday.
“We are definitely excited,” stated Randall Jean, associate professor of electrical and computer engineering at Baylor. “This is a relatively new area the market is exploring and we’ve demonstrated that using microwave energy can work.”
The sensor uses electromagnetic waves to measure blood glucose levels in the body. As the energy goes from the sensor through the skin and back to the sensor, the glucose level is measured through the transference of energy. Jean said the microwave frequency range is wide enough to isolate the effect of sugar in the blood and minimize the characteristics of other things like body fat and bone, which could alter accurate readings. Jean also said using electromagnetic waves is relatively safe because they do not ionize the body’s molecules like x-rays can do.
To measure glucose levels, users must press their thumb against the sensor, and a new study by the Baylor researchers shows that the sensor is accurate. Researchers took samples of nearly 20 people and compared those samples to levels measured by an over-the-counter commercial sensor. The researchers found Baylor’s noninvasive sensor has the potential of achieving the same or even better accuracy than current commercial sensors, many of which prick the finger to sample blood.
“The sensor passed its first simple quantitative test,” Jean said. “It can provide useful information to help the user decide what course of action they should take.”
Reckitt Benckiser CEO says Adams acquisition may lead to U.S. markets
BERKSHIRE, England While there are no immediate plans to bring Boots Healthcare International across the pond to American markets, Adams Respiratory was acquired, in part, to afford Reckitt Benckiser the ability to do that, Bart Becht, Reckitt Benckiser chief executive officer, explained to analysts during a conference call last week.
“[Adams] was very strategic for us as a company because it’s one of the few targets that allows us to get a healthcare infrastructure in the U.S., which we don’t have. And to build that organically is extremely difficult and costly,” Becht said. “Financially it makes sense simply because the very high growth that is in that business. Clearly if this would have been an ordinary low-growth healthcare business, we would have bid a very different amount of money or we would have walked away from it. … It’s a high growth business.”
Reckitt Benckiser officially closed the Adams deal Jan. 30 in a deal valued at approximately $2.3 billion. As a result of the merger, Adams shares will be delisted and cease to trade on the NASDAQ Global Select Market.
Shaklee debuts three Cinch weight-loss products
PLEASANTON, Calif. Shaklee Corporation on Tuesday introduced three products to its Cinch Inch Loss Plan—two Cinch Meal-in-a-Bars (berry almond crunch and peanut butter chocolate chip) and a Cinch Strawberry Shake Mix.
Each bar contains as many as 270 calories, is fortified with 6 grams of dietary fiber and are both low-glycemic and kosher-certified. The Cinch Strawberry Shake contains 24 grams of protein and 35 percent of the daily value for 21 vitamins and minerals in addition to the 6 grams of dietary fiber.